Medical AI solutions company VUNO obtains CE Mark for five of its solutions
Founded in South Korea in 2014, medical AI solutions development company VUNO announced that they have received the Class IIa CE markings for five of their AI solutions. The five CE marked solutions are: VUNO Med –BoneAge – VUNO’s first regulatory approved product, which assists in assessing bone age based on a child’s left-hand X-ray… Read More »